Sign up TODAY and unlock a FREE one month trial of all premium AddOns - reach out to our support team to activate your access!
Sign Up
Home Mf Research Hdfc Pharma And Healthcare Fund Regular Plan Growth
HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Equity Equity Sectoral Thematic
Fund House : HDFC Mutual Fund
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
NAV (as on 2025-06-23)
16.33 -0.06%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
2.24%
Expense Ratio (Direct)
1.01%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-16 ₹1,000.00 ₹973.53
-2.65 %
Two Week 2025-06-09 ₹1,000.00 ₹993.61
-0.64 %
One Month 2025-05-26 ₹1,000.00 ₹1,005.23
0.52 %
Three Months 2025-03-25 ₹3,000.00 ₹3,021.33
0.71 %
Six Months 2024-12-26 ₹6,000.00 ₹6,186.73
3.11 %
One Year 2024-06-24 ₹12,000.00 ₹12,667.44
5.56 %
Since Inception 2023-10-04 ₹21,000.00 ₹25,423.71
21.07 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology Equity 12.25
Divis Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 10.24
Cipla Ltd. Pharmaceuticals & Biotechnology Equity 7.00
Lupin Ltd. Pharmaceuticals & Biotechnology Equity 5.59
Max Healthcare Institute Limited Healthcare Services Equity 4.83
Glenmark Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 4.12
Ipca Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 3.99
Krishna Institute Of Medical Sciences Limited Healthcare Services Equity 3.95
Aster DM Healthcare Limited Healthcare Services Equity 3.92
Eris Lifesciences Ltd Pharmaceuticals & Biotechnology Equity 3.54
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 3.42
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology Equity 3.11
Wockhardt Ltd. Pharmaceuticals & Biotechnology Equity 2.95
Gland Pharma Ltd. Pharmaceuticals & Biotechnology Equity 2.75
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 2.63
Metropolis Healthcare Ltd. Healthcare Services Equity 2.42
Vijaya Diagnostic Centre Limited Healthcare Services Equity 2.39
Acutaas Chemicals Limited Pharmaceuticals & Biotechnology Equity 2.20
Piramal Pharma Limited Pharmaceuticals & Biotechnology Equity 2.12
Cohance Lifesciences Limited Pharmaceuticals & Biotechnology Equity 1.95
Dr. Lal Path Labs Ltd Healthcare Services Equity 1.78
Jubilant Pharmova Limited Pharmaceuticals & Biotechnology Equity 1.78
Fortis Healthcare Limited Healthcare Services Equity 1.62
Pfizer Ltd. Pharmaceuticals & Biotechnology Equity 1.62
Laxmi Dental Limited Healthcare Equipment & Supplies Equity 1.45
BAJAJ HEALTHCARE LIMITED - Prefential Issue Pharmaceuticals & Biotechnology Equity 1.25
Sai Life Sciences Limited Pharmaceuticals & Biotechnology Equity 1.13
Medi Assist Healthcare Services Limited Insurance Equity 1.08
Zydus Lifesciences Limited Pharmaceuticals & Biotechnology Equity 1.08
Ajanta Pharma Limited Pharmaceuticals & Biotechnology Equity 0.70
BAJAJ HEALTHCARE LIMITED Pharmaceuticals & Biotechnology Equity 0.35
TREPS - Tri-party Repo - Debt 1.08
Net Current Assets - - -0.29
Risk Ratios
Standard Deviation
14.882
Beta
0.753
Sharpe Ratio
3.264
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Nikhil Mathur (Over 14 years), Dhruv Muchhal (Over 10 years),
  • Expense ration regular : 2.24
  • Expense ration direct : 1.01
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹100.00
  • Type : equity
Exit load
1% within 30 days from the date of allotment.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?